Epigenetic and transcriptome responsiveness to ER modulation by tissue selective estrogen complexes in breast

Terri L Messier1,2, Joseph R Boyd1, Jonathan A R Gordon1,2

  • 1Department of Biochemistry, University of Vermont Larner College of Medicine, Burlington, VT, United States of America.

Plos One
|July 21, 2022
PubMed

Insights

Selective estrogen receptor modulators like bazedoxifene (BZA) can reduce breast cancer risk by altering epigenetic modifications in estrogen receptor-positive cells. BZA impacts gene expression and histone modifications, potentially restraining breast cancer development.

Area of Science:

  • Endocrinology
  • Epigenetics
  • Oncology

Background:

  • Selective estrogen receptor modulators (SERMs) are used for osteoporosis and may lower breast cancer (BCa) risk.
  • Estrogen receptor (ER) ligand administration can compromise cellular proliferation control.
  • Epigenetic mechanisms underlying hormone and SERM effects on BCa cells require elucidation.

Purpose of the Study:

  • To investigate the epigenetic impact of bazedoxifene (BZA) and estrogen compounds (E2, EC10) on gene expression and histone modifications in breast cancer cells.
  • To compare BZA's effects in ERα-positive (MCF7) and ERα-negative (MCF10A) cells.

Main Methods:

  • RNA sequencing (RNA-seq) for gene expression analysis.
  • Chromatin immunoprecipitation sequencing (ChIP-seq) to assess active (H3K4me3, H3K4ac, H3K27ac) and repressive (H3K27me3) histone modifications.
  • Treatment of MCF7 and MCF10A cells with 17β-estradiol (E2), estrogen compounds (EC10), and BZA, individually and in combination.

Main Results:

  • BZA combined with E2 or EC10 reduced estrogen-mediated histone modifications and gene expression in MCF7 ERα+ cells.
  • BZA had minimal effects on histone modifications and gene expression in MCF10A cells.
  • BZA altered H3K4ac patterns in MCF7 cells, affecting ERα target genes like GREB1 and proliferation-related genes.

Conclusions:

  • Bazedoxifene induces epigenetic changes that modulate estrogen receptor regulatory programs.
  • These BZA-induced epigenetic alterations target proliferation pathways, suggesting a mechanism for restraining breast cancer development.
  • BZA's effects are specific to ERα-positive cells, highlighting its potential in breast cancer risk reduction.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.1K
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
3.5K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
1.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.6K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.0K